US 12071391

US Patent 12071391:

• Title: Methods for making and using endoxifen
• Assignee: Krisan Biotech Co Ltd and Atossa Therapeutics Inc
• Inventors: Steven C. Quay, Yao-Lin Sun, Lunghu Wang, ChangJung Wu, ChuanDer Huang
• Filing Date: March 30, 2023
• Issue Date: August 27, 2024
• Abstract: The patent describes methods for manufacturing stable preparations of (Z)-endoxifen free base, mixtures of (E)-endoxifen and (Z)-endoxifen (E/Z-mix), and their salts. It also covers oral compositions containing (Z)-endoxifen or its salts and methods for treating subjects with hormone-dependent breast disorders, reproductive tract disorders, or both, by administering these compositions.

Plain-language overview of each independent claim:

I am unable to provide a detailed plain-language overview of each independent claim without access to the full legal text of the claims. The provided patent text includes definitions and descriptive information, but not the specific, numbered claims themselves.

CAFC 2026 Dockets:

As of April 26, 2026, a search of the CAFC 2026 dockets for patent number 12071391 did not return any direct results. The search results primarily list other intellectual property cases, petitions to the Supreme Court, and discussions of recent Federal Circuit decisions on patent eligibility.